Jessie L. Au

Affiliations: 
Ohio State University, Columbus, Columbus, OH 
Area:
Pharmacy, Pharmacology, Oncology, Molecular Biology
Google:
"Jessie Au"

Children

Sign in to add trainee
Teng-Kuang Yeh grad student 2002 Ohio State
Yilong Zhang grad student 2002 Ohio State
Max C. Tsai grad student 2003 Ohio State
Adam G. Ogden grad student 2004 Ohio State
Greg D. Lyness grad student 2005 Ohio State
Jianning Yang grad student 2009 Ohio State
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wang J, Yeung BZ, Wientjes MG, et al. (2021) A Quantitative Pharmacology Model of Exosome-Mediated Drug Efflux and Perturbation-Induced Synergy. Pharmaceutics. 13
Fang L, Kim MJ, Li Z, et al. (2018) Model-Informed Drug Development and Review for Generic Products: Summary of FDA Public Workshop. Clinical Pharmacology and Therapeutics
Wang J, Lu Z, Wang J, et al. (2015) Paclitaxel tumor priming promotes delivery and transfection of intravenous lipid-siRNA in pancreatic tumors. Journal of Controlled Release : Official Journal of the Controlled Release Society. 216: 103-110
Cui M, Au JL, Wientjes MG, et al. (2015) Intravenous siRNA Silencing of Survivin Enhances Activity of Mitomycin C in Human Bladder RT4 Xenografts. The Journal of Urology. 194: 230-7
Au JL, Guo P, Gao Y, et al. (2014) Multiscale tumor spatiokinetic model for intraperitoneal therapy. The Aaps Journal. 16: 424-39
Alvarez FJ, Kisseberth W, Hosoya K, et al. (2014) Postoperative adjuvant combination therapy with doxorubicin and noncytotoxic suramin in dogs with appendicular osteosarcoma. Journal of the American Animal Hospital Association. 50: 12-8
Tsai M, Lu Z, Wientjes MG, et al. (2013) Paclitaxel-loaded polymeric microparticles: quantitative relationships between in vitro drug release rate and in vivo pharmacodynamics. Journal of Controlled Release : Official Journal of the Controlled Release Society. 172: 737-44
Lustberg MB, Pant S, Ruppert AS, et al. (2012) Phase I/II trial of non-cytotoxic suramin in combination with weekly paclitaxel in metastatic breast cancer treated with prior taxanes. Cancer Chemotherapy and Pharmacology. 70: 49-56
Wang J, Lu Z, Gao Y, et al. (2012) Improving delivery and efficacy of nanomedicines in solid tumors: role of tumor priming. Nanomedicine (London, England). 6: 1605-20
Wong HL, Shen Z, Lu Z, et al. (2011) Paclitaxel tumor-priming enhances siRNA delivery and transfection in 3-dimensional tumor cultures. Molecular Pharmaceutics. 8: 833-40
See more...